Pharmather is planning to meet with the U.S. Food and Drug Administration (FDA) in hopes of reaching an agreement on the design of a future Phase 3 clinical trial testing […] The post Pharmather to seek FDA guidance for ketamine study in Parkinson’s appeared first on Parkinson's News Today.
